ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,137 | -37.0% | 820 | -50.1% | 0.00% | -100.0% |
| Q2 2023 | $640,326 | +63.4% | 1,643 | +56.2% | 0.00% | – |
| Q1 2023 | $391,955 | -17.2% | 1,052 | -15.8% | 0.00% | -100.0% |
| Q4 2022 | $473,159 | +11.6% | 1,249 | +4.1% | 0.00% | – |
| Q3 2022 | $424,000 | -6.8% | 1,200 | 0.0% | 0.00% | – |
| Q2 2022 | $455,000 | -98.9% | 1,200 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $39,819,000 | -24.6% | 126,284 | -16.2% | 0.03% | +21.4% |
| Q4 2021 | $52,779,000 | -16.3% | 150,717 | -27.8% | 0.03% | -20.0% |
| Q3 2021 | $63,026,000 | -0.6% | 208,695 | -0.9% | 0.04% | +2.9% |
| Q2 2021 | $63,419,000 | +9.5% | 210,644 | +0.1% | 0.03% | +13.3% |
| Q1 2021 | $57,941,000 | +108.7% | 210,397 | +122.8% | 0.03% | +114.3% |
| Q4 2020 | $27,768,000 | -42.3% | 94,421 | -48.5% | 0.01% | -51.7% |
| Q3 2020 | $48,147,000 | -2.3% | 183,401 | -16.2% | 0.03% | -17.1% |
| Q2 2020 | $49,280,000 | +29.5% | 218,801 | -24.2% | 0.04% | +6.1% |
| Q1 2020 | $38,049,000 | -8.1% | 288,836 | +12.0% | 0.03% | +10.0% |
| Q4 2019 | $41,395,000 | +30.3% | 257,880 | -7.5% | 0.03% | +11.1% |
| Q3 2019 | $31,764,000 | -13.8% | 278,730 | +7.1% | 0.03% | -18.2% |
| Q2 2019 | $36,860,000 | +83.2% | 260,344 | +61.5% | 0.03% | +83.3% |
| Q1 2019 | $20,122,000 | +8964.0% | 161,185 | +5921.1% | 0.02% | – |
| Q2 2018 | $222,000 | – | 2,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |